Pfizer (PFE) looks good, and has income growth of +82% in the last 12 months.
Its stock price was pushed down because of the FDA crack-down on anti-inflammatory (cox-2 inhibitors) like Vioxx. But, some think it was pushed down too much.
Also, Pfizer is promising to cut costs, buy back shares, and increase its dividend. The company has no credit or derivative exposure, and they have a strong pipeline of potential new drugs.
Microsoft (MSFT) also looks good. Sales growth +15% and income growth +79% in the last 12 months, and they are trying to buy yahoo.
Monday, 14 April 2008
2 Stocks To Think About...
Posted on 14:51 by Unknown
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment